Arrowhead Pharma (ARWR) PT Lowered to $41 at BofA Securities

February 11, 2025 5:22 AM

BofA Securities analyst Jason Gerberry lowered the price target on Arrowhead Pharma (NASDAQ: ARWR) to $41.00 (from $46.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found